{"disease":{"id":"p2-biliary-tract-cancer","name":"p2 biliary tract cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04492033","title":"A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Handok Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}